Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder.
about
Current guidelines in the management of interstitial cystitisLeukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coliProphylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies.Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan(®) instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated CystitisIncreased bladder permeability in interstitial cystitis/painful bladder syndrome.GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review.Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome.Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations.Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
P2860
Q26773527-69334CEE-E983-44C8-A49A-3F73D60541E9Q33671192-6B635797-9269-4E7C-9F77-BA2B318DE550Q33762850-B0E198DD-5369-4DAA-ABC5-B65E446C925DQ34990568-ACA84F8B-9671-49E6-B487-E8B437D058E6Q35168298-6AC5D156-8591-4552-9E7D-0E8B7A334E24Q35901614-9D4847D1-C547-4BD0-85E3-7FBC6D11C9A5Q36445359-7A6995C6-6C12-4708-8C6D-1E877E5097C2Q38025374-FE5928ED-C12E-40E6-968F-B2802F06F14EQ38150286-5DC02C57-C699-4C71-86E9-1374D75519B1Q38196864-00637BBA-4741-4ED0-801A-27324F63DA45Q41384895-1B55E4BF-D033-47D1-ABAD-F7AFCA726526Q47315500-7EE8F097-FF09-4AC8-B891-44AD98DAA7CA
P2860
Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Exogenous glycosaminoglycans c ...... mentally damaged mouse bladder
@nl
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@ast
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@en
type
label
Exogenous glycosaminoglycans c ...... mentally damaged mouse bladder
@nl
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@ast
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@en
prefLabel
Exogenous glycosaminoglycans c ...... mentally damaged mouse bladder
@nl
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@ast
Exogenous glycosaminoglycans c ...... entally damaged mouse bladder.
@en
P2860
P356
P1433
P1476
Exogenous glycosaminoglycans c ...... mentally damaged mouse bladder
@en
P2093
Jean Coffman
Kimberly D Kyker
P2860
P2888
P356
10.1186/1471-2490-5-4
P407
P577
2005-03-23T00:00:00Z
P5875
P6179
1019632160